We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Economical Method of Gene Silencing

By Biotechdaily staff writers
Posted on 27 Jan 2004
An alternative, more efficient way to accomplish the specific inhibition of gene functions by means of RNAs has been developed.

Currently, small interfering (si) RNAs are the method of choice to "knockdown” the function of particular genes, thereby offering clues about which genes are responsible for the expression of a particular bodily function. However, the application of these molecules has proven to be inefficient, their chemical synthesis is very expensive, and their use in high-throughput screening experiments is uneconomical. An alternative method of gene silencing has been developed by the nonprofit German Resource Center for Genome Research (RZPD, Berlin, Germany).

To use this method, RZPD first manufactured and verified gene-specific products for some 36,000 Unigene Clusters. These were represented by polymerase chain reaction (PCR) products, which were amplified using two gene-specific primers per gene, avoiding repetitive or conserved sequences. Then T7 promoters were added to convert these double stranded (ds)DNAs into dsRNAs by in vitro transcription. These long dsRNA molecules can be cut by Dicer or RNaseII (exonuclease II) into functional siRNAs. The final products are potent tools for the specific knockdown of genes, often superior to synthesized siRNA oligos.

RZPD is a service center for genomics and proteomics research. Based on one of the largest clone collections worldwide, it provides high quality research material, high throughput technology, and automation solutions for academic institutions as well as for industry. A wide variety of materials and services are available. No intellectual property is claimed by RZPD for results derived from the use of its material.




Related Links:
RZPD

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Sample Transportation System
Tempus1800 Necto

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
27 Jan 2004  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
27 Jan 2004  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
27 Jan 2004  |   BioResearch